{"transactions":[{"id":686617,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:09:36.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001194020-26-000015","document":"wk-form4_1786741773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000015/wk-form4_1786741773.xml","form_type":"4"}},{"id":686616,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-08-14T21:09:36.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":604,"price":46.57,"value":28128.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":9129,"source":{"system":"sec-edgar","filing":"0001194020-26-000015","document":"wk-form4_1786741773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000015/wk-form4_1786741773.xml","form_type":"4"}},{"id":686615,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-08-14T21:09:36.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":9733,"source":{"system":"sec-edgar","filing":"0001194020-26-000015","document":"wk-form4_1786741773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000015/wk-form4_1786741773.xml","form_type":"4"}},{"id":699866,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:05:56.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":1250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001194020-26-000013","document":"wk-form4_1785531954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000013/wk-form4_1785531954.xml","form_type":"4"}},{"id":850661,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850660,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850659,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1450,"price":54.73,"value":79358.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":8232,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850658,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9682,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850657,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1433,"price":54.73,"value":78428.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":6682,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":850656,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:12:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8115,"source":{"system":"sec-edgar","filing":"0001194020-26-000010","document":"wk-form4_1773173570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000010/wk-form4_1773173570.xml","form_type":"4"}},{"id":865940,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:11:16.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":3000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000008","document":"wk-form4_1772572265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000008/wk-form4_1772572265.xml","form_type":"4"}},{"id":865939,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:11:16.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":3000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000008","document":"wk-form4_1772572265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000008/wk-form4_1772572265.xml","form_type":"4"}},{"id":879387,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:19:19.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001194020-26-000006","document":"wk-form4_1772140756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000006/wk-form4_1772140756.xml","form_type":"4"}},{"id":879386,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:19.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1279,"price":50.69,"value":64832.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":5115,"source":{"system":"sec-edgar","filing":"0001194020-26-000006","document":"wk-form4_1772140756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000006/wk-form4_1772140756.xml","form_type":"4"}},{"id":879385,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-26T21:19:19.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6394,"source":{"system":"sec-edgar","filing":"0001194020-26-000006","document":"wk-form4_1772140756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000006/wk-form4_1772140756.xml","form_type":"4"}},{"id":881710,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881709,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881708,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":3375,"derivative":{"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881707,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1524,"price":50.86,"value":77510.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":3894,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881706,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5418,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881705,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":50.86,"value":12308.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":2418,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881704,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2660,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881703,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":603,"price":51.35,"value":30964.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":2160,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":881702,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2026-02-25T22:22:00.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2763,"source":{"system":"sec-edgar","filing":"0001194020-26-000004","document":"wk-form4_1772058117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000004/wk-form4_1772058117.xml","form_type":"4"}},{"id":890403,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:49:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001194020-26-000002","document":"wk-form4_1771624144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000002/wk-form4_1771624144.xml","form_type":"4"}},{"id":890402,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-20T21:49:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 18, 2027."}],"balance_after":17500,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001194020-26-000002","document":"wk-form4_1771624144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402026000002/wk-form4_1771624144.xml","form_type":"4"}},{"id":1055541,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-08-26T20:18:31.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":11780,"price":44.49,"value":524092.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.40 to $44.66, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":1246,"source":{"system":"sec-edgar","filing":"0001194020-25-000004","document":"wk-form4_1756239508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000119402025000004/wk-form4_1756239508.xml","form_type":"4"}},{"id":1211846,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2025-03-11T20:15:41.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0001628280-25-011984","document":"wk-form4_1741724133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025011984/wk-form4_1741724133.xml","form_type":"4"}},{"id":1211845,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2025-03-11T20:15:41.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001628280-25-011984","document":"wk-form4_1741724133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025011984/wk-form4_1741724133.xml","form_type":"4"}},{"id":1211844,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-11T20:15:41.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":955,"price":32.06,"value":30617.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":12681,"source":{"system":"sec-edgar","filing":"0001628280-25-011984","document":"wk-form4_1741724133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025011984/wk-form4_1741724133.xml","form_type":"4"}},{"id":1211843,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-11T20:15:41.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024."}],"balance_after":13636,"source":{"system":"sec-edgar","filing":"0001628280-25-011984","document":"wk-form4_1741724133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025011984/wk-form4_1741724133.xml","form_type":"4"}},{"id":1211842,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-11T20:15:41.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1062,"price":32.06,"value":34047.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":11836,"source":{"system":"sec-edgar","filing":"0001628280-25-011984","document":"wk-form4_1741724133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025011984/wk-form4_1741724133.xml","form_type":"4"}},{"id":1211841,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-11T20:15:41.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023."}],"balance_after":12898,"source":{"system":"sec-edgar","filing":"0001628280-25-011984","document":"wk-form4_1741724133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025011984/wk-form4_1741724133.xml","form_type":"4"}},{"id":1221976,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-05T21:23:11.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1330,"price":33.05,"value":43956.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":10898,"source":{"system":"sec-edgar","filing":"0001628280-25-010487","document":"wk-form4_1741209786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025010487/wk-form4_1741209786.xml","form_type":"4"}},{"id":1221975,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-05T21:23:11.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1587,"price":33.05,"value":52450.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":12228,"source":{"system":"sec-edgar","filing":"0001628280-25-010487","document":"wk-form4_1741209786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025010487/wk-form4_1741209786.xml","form_type":"4"}},{"id":1221974,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-03-05T21:23:11.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":276,"price":33.05,"value":9121.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":13815,"source":{"system":"sec-edgar","filing":"0001628280-25-010487","document":"wk-form4_1741209786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025010487/wk-form4_1741209786.xml","form_type":"4"}},{"id":1227307,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2025-03-04T21:20:01.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":1800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0001628280-25-009869","document":"wk-form4_1741123193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025009869/wk-form4_1741123193.xml","form_type":"4"}},{"id":1227306,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2025-03-04T21:20:01.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":2000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001628280-25-009869","document":"wk-form4_1741123193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025009869/wk-form4_1741123193.xml","form_type":"4"}},{"id":1249233,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:16:54.000Z","date":"2025-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001628280-25-007526","document":"wk-form4_1740446208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007526/wk-form4_1740446208.xml","form_type":"4"}},{"id":1249232,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:16:54.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":9000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001628280-25-007526","document":"wk-form4_1740446208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007526/wk-form4_1740446208.xml","form_type":"4"}},{"id":1249231,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:16:54.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":500,"derivative":{"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001628280-25-007526","document":"wk-form4_1740446208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007526/wk-form4_1740446208.xml","form_type":"4"}},{"id":1249230,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-02-25T01:16:54.000Z","date":"2025-02-23","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14091,"source":{"system":"sec-edgar","filing":"0001628280-25-007526","document":"wk-form4_1740446208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007526/wk-form4_1740446208.xml","form_type":"4"}},{"id":1249229,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-02-25T01:16:54.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11591,"source":{"system":"sec-edgar","filing":"0001628280-25-007526","document":"wk-form4_1740446208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007526/wk-form4_1740446208.xml","form_type":"4"}},{"id":1249228,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2025-02-25T01:16:54.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8591,"source":{"system":"sec-edgar","filing":"0001628280-25-007526","document":"wk-form4_1740446208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007526/wk-form4_1740446208.xml","form_type":"4"}},{"id":1252492,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-21T21:43:23.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":4500,"derivative":{"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001628280-25-007156","document":"wk-form4_1740174196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007156/wk-form4_1740174196.xml","form_type":"4"}},{"id":1252491,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-21T21:43:23.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 19, 2026."}],"balance_after":40000,"derivative":{"exercise_price":33.52,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-25-007156","document":"wk-form4_1740174196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000162828025007156/wk-form4_1740174196.xml","form_type":"4"}},{"id":1615177,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T22:01:34.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-24-028273","document":"tm247055-22_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924028273/tm247055-22_4seq1.xml","form_type":"4"}},{"id":1615176,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2024-02-27T22:01:34.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":1314,"price":29.06,"value":38184.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":7190,"source":{"system":"sec-edgar","filing":"0001104659-24-028273","document":"tm247055-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924028273/tm247055-22_4seq1.xml","form_type":"4"}},{"id":1615175,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2024-02-27T22:01:34.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8504,"source":{"system":"sec-edgar","filing":"0001104659-24-028273","document":"tm247055-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924028273/tm247055-22_4seq1.xml","form_type":"4"}},{"id":1618952,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-26T22:00:44.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in four equal annual installments beginning on February 22, 2025."}],"balance_after":50000,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-027567","document":"tm247055-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924027567/tm247055-3_4seq1.xml","form_type":"4"}},{"id":1618951,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T22:00:44.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-24-027567","document":"tm247055-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924027567/tm247055-3_4seq1.xml","form_type":"4"}},{"id":1618950,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T22:00:44.000Z","date":"2024-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":1000,"derivative":{"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001104659-24-027567","document":"tm247055-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924027567/tm247055-3_4seq1.xml","form_type":"4"}},{"id":1618949,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2024-02-26T22:00:44.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":6004,"source":{"system":"sec-edgar","filing":"0001104659-24-027567","document":"tm247055-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465924027567/tm247055-3_4seq1.xml","form_type":"4"}},{"id":1760533,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2023-10-13T21:00:09.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-23-109142","document":"tm2328365-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923109142/tm2328365-1_4seq1.xml","form_type":"4"}},{"id":1760532,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-10-13T21:00:09.000Z","date":"2023-10-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1911,"price":26.91,"value":51425.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting."}],"balance_after":5089,"source":{"system":"sec-edgar","filing":"0001104659-23-109142","document":"tm2328365-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923109142/tm2328365-1_4seq1.xml","form_type":"4"}},{"id":1760531,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-10-13T21:00:09.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001104659-23-109142","document":"tm2328365-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923109142/tm2328365-1_4seq1.xml","form_type":"4"}},{"id":1763408,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2023-10-06T21:02:42.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual\nperformance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual\nperformance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":4000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-23-107539","document":"tm2327888-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923107539/tm2327888-1_4seq1.xml","form_type":"4"}},{"id":1894837,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Units","published_at":"2023-05-12T21:00:45.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on May 3, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-059842","document":"tm2315575-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923059842/tm2315575-3_4seq1.xml","form_type":"4"}},{"id":1894836,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-05-12T21:00:45.000Z","date":"2023-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":709,"price":36.47,"value":25857.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting."}],"balance_after":2650,"source":{"system":"sec-edgar","filing":"0001104659-23-059842","document":"tm2315575-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923059842/tm2315575-3_4seq1.xml","form_type":"4"}},{"id":1894835,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-05-12T21:00:45.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on May 3, 2022."}],"balance_after":3359,"source":{"system":"sec-edgar","filing":"0001104659-23-059842","document":"tm2315575-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923059842/tm2315575-3_4seq1.xml","form_type":"4"}},{"id":1900743,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Units","published_at":"2023-05-08T21:00:40.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":1500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-057226","document":"tm2314899-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923057226/tm2314899-2_4seq1.xml","form_type":"4"}},{"id":1920830,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-04-12T21:01:02.000Z","date":"2023-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001104659-23-044666","document":"tm2312277-4_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923044666/tm2312277-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-24"}},{"id":1920829,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-04-12T21:01:02.000Z","date":"2023-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":193,"price":38.57,"value":7444.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":1148,"source":{"system":"sec-edgar","filing":"0001104659-23-044666","document":"tm2312277-4_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923044666/tm2312277-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-24"}},{"id":1920828,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-04-12T21:01:02.000Z","date":"2023-02-22","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 841 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":1341,"source":{"system":"sec-edgar","filing":"0001104659-23-044666","document":"tm2312277-4_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923044666/tm2312277-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-24"}},{"id":1922226,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2023-04-10T21:00:35.000Z","date":"2023-03-14","kind":"exercise","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on May 3, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-043635","document":"tm2311944d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923043635/tm2311944d2_4seq1.xml","form_type":"4"}},{"id":1922225,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-04-10T21:00:35.000Z","date":"2023-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":789,"price":38.65,"value":30494.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting."}],"balance_after":2052,"source":{"system":"sec-edgar","filing":"0001104659-23-043635","document":"tm2311944d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923043635/tm2311944d2_4seq1.xml","form_type":"4"}},{"id":1922224,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-04-10T21:00:35.000Z","date":"2023-03-14","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on May 3, 2022."}],"balance_after":2841,"source":{"system":"sec-edgar","filing":"0001104659-23-043635","document":"tm2311944d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923043635/tm2311944d2_4seq1.xml","form_type":"4"}},{"id":1989927,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-27T22:03:10.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-026086","document":"tm237737-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923026086/tm237737-19_4seq1.xml","form_type":"4"}},{"id":1989926,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-27T22:03:10.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 23, 2024."}],"balance_after":40000,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-026086","document":"tm237737-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923026086/tm237737-19_4seq1.xml","form_type":"4"}},{"id":1992691,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-02-24T22:03:42.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001104659-23-025371","document":"tm237737-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923025371/tm237737-9_4seq1.xml","form_type":"4"}},{"id":1992690,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Common Stock","published_at":"2023-02-24T22:03:42.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 841 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":1341,"source":{"system":"sec-edgar","filing":"0001104659-23-025371","document":"tm237737-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923025371/tm237737-9_4seq1.xml","form_type":"4"}},{"id":2003133,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Performance Share Unit","published_at":"2023-02-21T22:02:33.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":1500,"derivative":{"exercise_price":0,"expiration_date":"2023-04-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-023836","document":"tm237193-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465923023836/tm237193-5_4seq1.xml","form_type":"4"}},{"id":2371662,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:14:47.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023."}],"balance_after":2000,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-22-027391","document":"tm227764-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465922027391/tm227764-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-02-24"}},{"id":2371661,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-25T22:14:47.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 22, 2023."}],"balance_after":25000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-027391","document":"tm227764-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465922027391/tm227764-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-02-24"}},{"id":2374353,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T02:25:16.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":2000,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-22-026879","document":"tm227622-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465922026879/tm227622-5_4seq1.xml","form_type":"4"}},{"id":2374352,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-25T02:25:16.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 22, 2023."}],"balance_after":25000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-026879","document":"tm227622-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465922026879/tm227622-5_4seq1.xml","form_type":"4"}},{"id":2592075,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-08-24T21:17:00.000Z","date":"2021-08-23","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on August 23, 2021."}],"balance_after":85000,"derivative":{"exercise_price":25.09,"expiration_date":"2031-08-23","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001104659-21-109013","document":"tm2125812-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194020/000110465921109013/tm2125812-2_4seq1.xml","form_type":"4"}},{"id":2705179,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-19T20:45:46.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All stock information is adjusted to reflect a twenty-five-to-one reverse stock split effected on August 29, 2019."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of restricted stock units (\"RSUs\") granted in May 2019 that convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 17, 2019, the Reporting Person was granted 1,750 RSUs (on a post-stock split basis). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one-third of the award on the first, second and third anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 17, 2019, the Reporting Person was granted 1,750 RSUs (on a post-stock split basis). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one-third of the award on the first, second and third anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant."}],"balance_after":584,"derivative":{"underlying":"Common Stock","underlying_shares":583},"source":{"system":"sec-edgar","filing":"0001079973-21-000398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997321000398/ownership.xml","form_type":"4"}},{"id":2705178,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-19T20:45:46.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All stock information is adjusted to reflect a twenty-five-to-one reverse stock split effected on August 29, 2019."}],"balance_after":1509,"source":{"system":"sec-edgar","filing":"0001079973-21-000398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997321000398/ownership.xml","form_type":"4"}},{"id":2805678,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Award","published_at":"2021-03-05T21:29:44.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of OpGen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 3, 2021 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in installments beginning March 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 3, 2021 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in installments beginning March 3, 2022."}],"balance_after":42500,"derivative":{"underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001079973-21-000154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997321000154/ownership.xml","form_type":"4"}},{"id":2805677,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Award","published_at":"2021-03-05T21:29:44.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is based on the closing price for shares of OpGen common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option granted under the terms and provisions of the OpGen 2015 Equity Incentive Plan. The stock option vests in two equal annual installments beginning on March 3, 2022."}],"balance_after":42500,"derivative":{"exercise_price":1.91,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001079973-21-000154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997321000154/ownership.xml","form_type":"4"}},{"id":3015896,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Award","published_at":"2020-10-02T21:36:02.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of stock options have a four year vesting schedule, vesting 25% on the first anniversary of the date of grant and the remaining options vesting 6.25% on the quarterly anniversary of the first vesting date for a period of three years, as long as the Reporting Person continues providing services to the Company on each such vesting date."}],"balance_after":210000,"derivative":{"exercise_price":2.12,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001079973-20-000839","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997320000839/ownership.xml","form_type":"4"}},{"id":3142446,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-05-20T00:36:13.000Z","date":"2020-05-17","kind":"exercise","acquired":false,"shares":583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All stock information is adjusted to reflect a twenty-five-to-one reverse stock split effected on August 29, 2019."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of restricted stock units (\"RSUs\") granted in May 2019 that convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 17, 2019, the Reporting Person was granted 1,750 RSUs (on a post-stock split basis). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one-third of the award on the first, second and third anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 17, 2019, the Reporting Person was granted 1,750 RSUs (on a post-stock split basis). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one-third of the award on the first, second and third anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant."}],"balance_after":1167,"derivative":{"underlying":"Common Stock","underlying_shares":583},"source":{"system":"sec-edgar","filing":"0001079973-20-000437","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997320000437/ownership.xml","form_type":"4"}},{"id":3142445,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T00:36:13.000Z","date":"2020-05-17","kind":"exercise","acquired":true,"shares":583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All stock information is adjusted to reflect a twenty-five-to-one reverse stock split effected on August 29, 2019."}],"balance_after":926,"source":{"system":"sec-edgar","filing":"0001079973-20-000437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997320000437/ownership.xml","form_type":"4"}},{"id":3374275,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Financial Officer"}}],"security":"Restricted Stock Option","published_at":"2019-11-12T23:33:11.000Z","date":"2019-11-10","kind":"exercise","acquired":false,"shares":12,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2019, one-fourth of a restricted stock unit award granted on November 10, 2015 vested and was earned."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments from the date of grant, with acceleration of vesting in certain circumstances associated with a change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments from the date of grant, with acceleration of vesting in certain circumstances associated with a change of control."}],"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12},"source":{"system":"sec-edgar","filing":"0001079973-19-000581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997319000581/ownership.xml","form_type":"4"}},{"id":3374274,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-12T23:33:11.000Z","date":"2019-11-10","kind":"exercise","acquired":true,"shares":12,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2019, one-fourth of a restricted stock unit award granted on November 10, 2015 vested and was earned."}],"balance_after":345,"source":{"system":"sec-edgar","filing":"0001079973-19-000581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997319000581/ownership.xml","form_type":"4"}},{"id":3518264,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-20T21:32:47.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to acquire one share of Common Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are subject to forfeiture, which forfeiture restrictions will lapse as to one-third of the award on the first, second and third anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units are subject to forfeiture, which forfeiture restrictions will lapse as to one-third of the award on the first, second and third anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant."}],"balance_after":35000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001079973-19-000319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997319000319/ownership.xml","form_type":"4"}},{"id":4029885,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-02-27T22:19:51.000Z","date":"2018-02-23","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All stock information is adjusted to reflect a one-for-twenty-five reverse stock split effected on January 17, 2018."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to acquire one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents lapse of forfeiture of restricted stock units granted in August 2017 upon achievement of a milestone event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents lapse of forfeiture of restricted stock units granted in August 2017 upon achievement of a milestone event."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001140361-18-010542","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036118010542/doc1.xml","form_type":"4"}},{"id":4029884,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-27T22:19:51.000Z","date":"2018-02-23","kind":"exercise","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All stock information is adjusted to reflect a one-for-twenty-five reverse stock split effected on January 17, 2018."}],"balance_after":6408,"source":{"system":"sec-edgar","filing":"0001140361-18-010542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036118010542/doc1.xml","form_type":"4"}},{"id":4089629,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Award","published_at":"2018-01-25T21:59:24.000Z","date":"2018-01-23","kind":"grant","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on January 23, 2019 and 6.25% on the quarterly anniversary of the first vesting date for a period of three years."}],"balance_after":12000,"derivative":{"exercise_price":4.02,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-18-003235","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036118003235/doc1.xml","form_type":"4"}},{"id":4163516,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-11-14T21:43:09.000Z","date":"2017-11-10","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2017, one-fourth of a restricted stock unit award granted on November 10, 2015 vested and was earned."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments from the date of grant, with acceleration of vesting in certain circumstances associated with a change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments from the date of grant, with acceleration of vesting in certain circumstances associated with a change of control."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001140361-17-042839","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117042839/doc1.xml","form_type":"4"}},{"id":4163515,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-14T21:43:09.000Z","date":"2017-11-10","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2017, one-fourth of a restricted stock unit award granted on November 10, 2015 vested and was earned."}],"balance_after":125216,"source":{"system":"sec-edgar","filing":"0001140361-17-042839","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117042839/doc1.xml","form_type":"4"}},{"id":4236422,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-08-11T20:22:53.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of OpGen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest upon the successful launch of OpGen, Inc.'s cUTI RUO mAST."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest upon the successful launch of OpGen, Inc.'s cUTI RUO mAST."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-17-031408","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117031408/doc1.xml","form_type":"4"}},{"id":4236421,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Award","published_at":"2017-08-11T20:22:53.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60000,"derivative":{"exercise_price":0.295,"exercise_date":"2018-08-09","expiration_date":"2027-08-09","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001140361-17-031408","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117031408/doc1.xml","form_type":"4"}},{"id":4255198,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-07-18T20:10:45.000Z","date":"2017-07-18","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65000,"derivative":{"exercise_price":0.425,"exercise_date":"2017-07-18","expiration_date":"2022-07-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001140361-17-028091","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117028091/doc1.xml","form_type":"4"}},{"id":4255197,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-18T20:10:45.000Z","date":"2017-07-18","kind":"purchase","acquired":true,"shares":65000,"price":0.4,"value":26000.0,"ownership":{"direct":true},"balance_after":118966,"source":{"system":"sec-edgar","filing":"0001140361-17-028091","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117028091/doc1.xml","form_type":"4"}},{"id":4421128,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Award","published_at":"2017-02-27T22:12:01.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on February 23, 2018 and 6.25% quarterly thereafter on the first business day of each quarter for a period of three years."}],"balance_after":68000,"derivative":{"exercise_price":1.03,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001140361-17-009452","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117009452/doc1.xml","form_type":"4"}},{"id":4457015,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-02-10T20:42:10.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2016, one-fourth of a restricted stock unit award granted on November 10, 2015 vested and was earned, but the transaction was not reported on a timely basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments from the date of grant with the first installment having vested on November 10, 2016, with acceleration of vesting in certain circumstances associated with a change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments from the date of grant with the first installment having vested on November 10, 2016, with acceleration of vesting in certain circumstances associated with a change of control."}],"balance_after":18750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001140361-17-005767","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117005767/doc1.xml","form_type":"5"}},{"id":4457014,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":23284,"kind":"person","name":"DEC TIMOTHY C","position":1,"cik":"0001194020","reported_name":"DEC TIMOTHY C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-10T20:42:10.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2016, one-fourth of a restricted stock unit award granted on November 10, 2015 vested and was earned, but the transaction was not reported on a timely basis."}],"balance_after":53966,"source":{"system":"sec-edgar","filing":"0001140361-17-005767","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293818/000114036117005767/doc1.xml","form_type":"5"}}]}